Wall Street: good start to the week in sight


Futures on the main American indices (+ 0.3% on the S & P500, + 0.5% on the Nasdaq-100) point to an opening on the right foot for the equity indices, after a three-day weekend due to the closing Friday Christmas Eve.

In the absence of major macroeconomic data, stock market news for the next few days could once again be punctuated by the issue of the Covid-19 pandemic and the consequences of the Omicron variant on the economic recovery.

‘The cancellation of several thousand flights in the United States on Sunday as well as the return to port, according to several media, of at least three cruise ships due to cases of Covid-19 on board are fueling concerns’, underlines – we also at Kiplink Finance.

However, a certain confidence continues to prevail on this file, after preliminary data from various studies, published last week, having shown that Omicron remains less likely to lead to hospitalizations than Delta.

In the news, Merck and Ridgeback announced Friday that they had received, in Japan, a special approval for the emergency use of molnupiravir, their experimental drug for infectious diseases caused by SARS-CoV-2.

Boeing said it won a contract worth more than $ 239 million from the US military for the re-engineization of Apache attack helicopters assembled by the aeronautics and defense gauntlet.

Copyright (c) 2021 CercleFinance.com. All rights reserved.



Source link -88